O'Neil KT - Search Results

1

Protein engineering strategies for sustained glucagon-like peptide-1 receptor-dependent control of glucose homeostasis.

Picha KM, Cunningham MR, Drucker DJ, Mathur A, Ort T, Scully M, Soderman A, Spinka-Doms T, Stojanovic-Susulic V, Thomas BA, O'Neil KT. Picha KM, et al. Diabetes. 2008 Jul;57(7):1926-34. doi: 10.2337/db07-1775. Epub 2008 Apr 21. Diabetes. 2008. PMID: 18426860 Free PMC article.

2

CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.

Parlevliet ET, Schröder-van der Elst JP, Corssmit EP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H. Parlevliet ET, et al. J Pharmacol Exp Ther. 2009 Jan;328(1):240-8. doi: 10.1124/jpet.108.144154. Epub 2008 Oct 10. J Pharmacol Exp Ther. 2009. PMID: 18849357

3

Engineering peptide therapeutics using MIMETIBODY™ technology.

Picha K, Huang C, Bugelski P, O'Neil K. Picha K, et al. Methods Mol Biol. 2014;1088:125-45. doi: 10.1007/978-1-62703-673-3_9. Methods Mol Biol. 2014. PMID: 24146401

4

Development of mammalian production cell lines expressing CNTO736, a glucagon like peptide-1-MIMETIBODY: factors that influence productivity and product quality.

Dorai H, Nemeth JF, Cammaart E, Wang Y, Tang QM, Magill A, Lewis MJ, Raju TS, Picha K, O'Neil K, Ganguly S, Moore G. Dorai H, et al. Biotechnol Bioeng. 2009 May 1;103(1):162-76. doi: 10.1002/bit.22217. Biotechnol Bioeng. 2009. PMID: 19137588

5

GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice.

Parlevliet ET, Wang Y, Geerling JJ, Schröder-Van der Elst JP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H, Rensen PC. Parlevliet ET, et al. PLoS One. 2012;7(11):e49152. doi: 10.1371/journal.pone.0049152. Epub 2012 Nov 2. PLoS One. 2012. PMID: 23133675 Free PMC article.

6

Engineering a targeted delivery platform using Centyrins.

Goldberg SD, Cardoso RM, Lin T, Spinka-Doms T, Klein D, Jacobs SA, Dudkin V, Gilliland G, O'Neil KT. Goldberg SD, et al. Among authors: o neil kt. Protein Eng Des Sel. 2016 Dec;29(12):563-572. doi: 10.1093/protein/gzw054. Epub 2016 Oct 13. Protein Eng Des Sel. 2016. PMID: 27737926

7

Inhalation delivery of protein therapeutics.

Kane C, O'Neil K, Conk M, Picha K. Kane C, et al. Inflamm Allergy Drug Targets. 2013 Apr;12(2):81-7. doi: 10.2174/1871528111312020002. Inflamm Allergy Drug Targets. 2013. PMID: 23517644 Review.

8

Structure-based engineering of a monoclonal antibody for improved solubility.

Wu SJ, Luo J, O'Neil KT, Kang J, Lacy ER, Canziani G, Baker A, Huang M, Tang QM, Raju TS, Jacobs SA, Teplyakov A, Gilliland GL, Feng Y. Wu SJ, et al. Protein Eng Des Sel. 2010 Aug;23(8):643-51. doi: 10.1093/protein/gzq037. Epub 2010 Jun 11. Protein Eng Des Sel. 2010. PMID: 20543007

9

Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates.

Jacobs SA, Wu SJ, Feng Y, Bethea D, O'Neil KT. Jacobs SA, et al. Pharm Res. 2010 Jan;27(1):65-71. doi: 10.1007/s11095-009-0007-z. Epub 2009 Nov 13. Pharm Res. 2010. PMID: 19911257

10

Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.

Tornetta M, Fisher D, O'Neil K, Geng D, Schantz A, Brigham-Burke M, Lombardo D, Fink D, Knight D, Sweet R, Tsui P. Tornetta M, et al. J Immunol Methods. 2007 Dec 1;328(1-2):34-44. doi: 10.1016/j.jim.2007.08.008. Epub 2007 Sep 4. J Immunol Methods. 2007. PMID: 17888945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters